Women who have surgery for ovarian cancer have better outcomes if they are treated at high-volume hospitals, according to researchers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University ...
not rated yet |
0
Although patients may feel anxious waiting weeks from the time of their first doctor visit to evaluate their breast until they have breast cancer surgery, new findings from Fox Chase Cancer Center show that these waits are ...
not rated yet |
0
(HealthDay)—Patients with advanced solid tumors receiving cisplatin-based chemotherapy regimens have a significantly higher risk of having a venous thromboembolic event (VTE) compared with those who do ...
not rated yet |
0
(HealthDay)—For patients with treatment-naive Hodgkin's lymphoma (HL) staged using [18F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT), routine bone marrow biopsy (BMB) has little or no ther ...
not rated yet |
0
Radiolabeled agents are powerful tools for targeting and killing cancer cells and may help improve outcomes and lengthen survival times of patients with advanced disease that has spread beyond the initial ...
not rated yet |
0
A large population- and health systems-based prospective study reports earlier discussions about end of life (EOL) care preferences are strongly associated with less aggressive care in the last days of life and increased ...
not rated yet |
0
A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, recently e-published ahead of print by the Journal of Clinical Oncology, sugges ...
5 / 5 (1) |
0
|
(HealthDay)—Treatment of lymphoma patients with the gonadotropin-releasing hormone agonist (GnRHa) triptorelin plus norethisterone does not reduce the rate of chemotherapy-induced premature ovarian failure ...
not rated yet |
0
(HealthDay)—Offering breast cancer patients a relatively short regimen of acupuncture alongside standard treatment can help alleviate some of the crippling fatigue that often accompanies the disease, according ...
5 / 5 (1) |
0
(HealthDay)—Definitional issues and non-acceptance of patients receiving chemotherapy are the barriers to earlier referral to specialized palliative care (SPC) by oncologists, according to a study published ...
not rated yet |
0
(HealthDay)—More intensive chemotherapy (every two weeks versus every three weeks) improves event-free survival for patients with localized Ewing sarcoma, according to a study published online Oct. 22 in the Journal of ...
not rated yet |
0
heralded for its low complication rates—actually results in more complications than whole-breast radiation one year after treatment, Yale School of Medicine researchers report in the October issue of the Journal of Clinical On ...
not rated yet |
0
|
(HealthDay)—While the majority of survivors of pediatric embryonal tumors display positive social outcomes several years after diagnosis and treatment, specific risk factors may affect social adjustment ...
not rated yet |
0
(HealthDay)—Lexatumumab, an agonistic, full human monoclonal antibody against tumor necrosis factor-related apoptosis-inducing ligand receptor 2, is well tolerated and may lessen certain clinical symptoms ...
5 / 5 (1) |
0
Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.
not rated yet |
0
